obecabtagene autoleucel 410000000 CELLS/ML Injection

RxCUI: 2700168
RxNorm name: obecabtagene autoleucel 410000000 CELLS/ML Injection
Display name: obecabtagene autoleucel 410000000 CELLS/ML Injection
Full name: obecabtagene autoleucel 410000000 CELLS/ML Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125813	Aucatzyl	Obecabtagene autoleucel	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AUCATZYL	OBECABTAGENE AUTOLEUCEL	Autolus Inc.	4fef6986-b988-45e4-8c20-b14f0ef1f538	2026-06-23	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2700168

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
4fef6986-b988-45e4-8c20-b14f0ef1f538	obecabtagene autoleucel 410000000 CELLS/ML Injection	SCD	5	These highlights do not include all the information needed to use AUCATZYL safely and effectively. See full prescribing information for AUCATZYL. AUCATZYL ® (obecabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 2024	20260227
4fef6986-b988-45e4-8c20-b14f0ef1f538	obecabtagene autoleucel 410000000 CELLS/ML Injection	PSN	5	These highlights do not include all the information needed to use AUCATZYL safely and effectively. See full prescribing information for AUCATZYL. AUCATZYL ® (obecabtagene autoleucel) suspension for intravenous infusion Initial U.S. Approval: 2024	20260227